PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9041221-1	1997	Woo et al (Nature 368:750-753) reported that parenteral administration of paclitaxel arrested the striking renal enlargement and prolonged life in C57BL/6J-cpk/cpk mice with a rapidly progressive form of polycystic kidney disease (PKD).	Paclitaxel	74-84	cystin 1	Mus musculus	156-159	
9150481-2	1997	Cpk/cpk mice treated weekly with paclitaxel (Taxol) can live to over six months of age.	Paclitaxel	33-43	cystin 1	Mus musculus	0-3	
9150481-2	1997	Cpk/cpk mice treated weekly with paclitaxel (Taxol) can live to over six months of age.	Paclitaxel	33-43	cystin 1	Mus musculus	4-7	
9150481-2	1997	Cpk/cpk mice treated weekly with paclitaxel (Taxol) can live to over six months of age.	Paclitaxel	45-50	cystin 1	Mus musculus	0-3	
9150481-2	1997	Cpk/cpk mice treated weekly with paclitaxel (Taxol) can live to over six months of age.	Paclitaxel	45-50	cystin 1	Mus musculus	4-7	
9150481-5	1997	We found that taxanes that are active in promoting microtubule assembly, including paclitaxel, 10-deactyl-taxol and cephalomannine increased the survival of polycystic cpk/cpk mice significantly longer than control animals.	Paclitaxel	83-93	cystin 1	Mus musculus	168-171	
9150481-7	1997	We conclude that the ability to promote microtubule assembly may be necessary for paclitaxel and related taxanes to modulate the progression of polycystic kidney progression in cpk/cpk mice.	Paclitaxel	82-92	cystin 1	Mus musculus	177-180	
9150481-7	1997	We conclude that the ability to promote microtubule assembly may be necessary for paclitaxel and related taxanes to modulate the progression of polycystic kidney progression in cpk/cpk mice.	Paclitaxel	82-92	cystin 1	Mus musculus	181-184	
9041221-1	1997	Woo et al (Nature 368:750-753) reported that parenteral administration of paclitaxel arrested the striking renal enlargement and prolonged life in C57BL/6J-cpk/cpk mice with a rapidly progressive form of polycystic kidney disease (PKD).	Paclitaxel	74-84	cystin 1	Mus musculus	160-163	
9041221-3	1997	Paclitaxel was administered by intraperitoneal injection to C57BL/6J-cpk/cpk mice and Han:SPRD-Cy/Cy rats with rapidly progressive PKD and to DBA/2FG-pcy/pcy mice and Han:SPRD-Cy/+ rats with slowly progressive PKD.	Paclitaxel	0-10	cystin 1	Mus musculus	69-72	
9041221-3	1997	Paclitaxel was administered by intraperitoneal injection to C57BL/6J-cpk/cpk mice and Han:SPRD-Cy/Cy rats with rapidly progressive PKD and to DBA/2FG-pcy/pcy mice and Han:SPRD-Cy/+ rats with slowly progressive PKD.	Paclitaxel	0-10	cystin 1	Mus musculus	73-76	
9041221-4	1997	Paclitaxel (150 micrograms/wk) prolonged the survival of cpk/cpk mice from 24.5 days to more than 65 days and decreased kidney weight relative to body weight from 16.5% at 21 days of age to 8.2% at more than 65 days of age.	Paclitaxel	0-10	cystin 1	Mus musculus	57-60	
9041221-4	1997	Paclitaxel (150 micrograms/wk) prolonged the survival of cpk/cpk mice from 24.5 days to more than 65 days and decreased kidney weight relative to body weight from 16.5% at 21 days of age to 8.2% at more than 65 days of age.	Paclitaxel	0-10	cystin 1	Mus musculus	61-64	
9041221-13	1997	We conclude that paclitaxel diminished the rate of renal enlargement and increased the life span of cpk/cpk mice but not Cy/Cy rats with rapidly progressive forms of PKD.	Paclitaxel	17-27	cystin 1	Mus musculus	100-103	
9041221-13	1997	We conclude that paclitaxel diminished the rate of renal enlargement and increased the life span of cpk/cpk mice but not Cy/Cy rats with rapidly progressive forms of PKD.	Paclitaxel	17-27	cystin 1	Mus musculus	104-107	
7908721-5	1994	The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size.	Paclitaxel	171-176	cystin 1	Mus musculus	4-7	
7908721-5	1994	The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size.	Paclitaxel	171-176	cystin 1	Mus musculus	75-78	
7908721-5	1994	The cpk mouse is a well-characterized recessive PKD model and we find that cpk/cpk mice develop PKD and die from uraemia by 4-5 weeks of age, but when treated weekly with taxol they survive for more than 200 days with minimal loss of renal function, show limited collecting-dust cyst enlargement, and attain adult size.	Paclitaxel	171-176	cystin 1	Mus musculus	75-78